Anmaw Shite Abat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anmaw Shite Abat has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Enyiew Alemnew Alamerew
Amhara Agricultural Research Institute, Debre Birhan Agricultural Research Centre, Debre Birhan, Ethiopia
5 shared publications - Mastewal Birhan
Department of Veterinary Pathobiology, College of Veterinary Medicine and Animal Sciences, University of Gondar, Gondar, Ethiopia
5 shared publications - Firdyawukal Abuhay Tafere
Department of Veterinary Pathobiology, College of Veterinary Medicine and Animal Sciences, University of Gondar, Gondar, Ethiopia
3 shared publications - Saddam Mohammed Ibrahim
College of Veterinary Medicine and Animal Sciences, University of Gondar, Gondar, Ethiopia
3 shared publications - Abebech Atinafu Yehulashet
Department of Veterinary Pharmacy, College of Veterinary Medicine and Animal Sciences, University of Gondar, Gondar, Ethiopia
2 shared publications - Abraham Belete Temesgen
Department of Veterinary Pathobiology, College of Veterinary Medicine and Animal Sciences, University of Gondar, Gondar, Ethiopia
2 shared publications
Latest Publications
- Open Access
- 23 July 2026
- Published by Springer Nature in Veterinary Research Communications
- Vol. 50 (5) , 476
Correction to: Seroprevalence and risk factors of African horse sickness in equines in central Gondar, Ethiopia
- 23 July 2026
- Published by Springer Nature in Veterinary Research Communications
- Vol. 50 (5) , 476
Open AccessCorrection to: Seroprevalence and risk factors of African horse sickness in equines in central Gondar, Ethiopia
- Open Access
- 8 July 2026
- Published by Springer Nature in Veterinary Research Communications
- Vol. 50 (5) , 445
Seroprevalence and risk factors of African horse sickness in equines in central Gondar, Ethiopia
African horse sickness is a severe vector-borne viral disease of equines, associated with high mortality and substantial economic losses. In Ethiopia, where equines are essential for transport and agriculture, the disease remains endemic, yet epidemiological data are limited in many areas. This study aimed to estimate the seroprevalence of African horse sickness virus (AHSV) and describe variation in seropositivity across selected factors in equines in the Central Gondar Zone, Ethiopia. A cross-sectional study was conducted from December 2024 to August 2025, during which 384 serum samples were collected and tested using a blocking enzyme-linked immunosorbent assay (bELISA). Of these, 310 were seropositive, giving an overall seroprevalence of 80.7% (95% CI: 76.4–84.6%). Seroprevalence was slightly higher in East Dembia (81.3%) than in West Dembia (79.9%). Univariable logistic regression showed no statistically significant associations between seropositivity and the evaluated variables ( p > 0.05). Although not statistically significant, higher odds were observed in donkeys and horses compared to mules, in older animals, and under sheltered management conditions. These findings indicate widespread exposure to AHSV in the study area. However, results should be interpreted cautiously due to the descriptive nature of the analysis. Further studies incorporating larger sample sizes, multivariable approaches, and complementary diagnostic methods are recommended to better understand infection dynamics. Strengthened vaccination, improved management practices, and effective vector control remain essential for reducing disease impact.
- 8 July 2026
- Published by Springer Nature in Veterinary Research Communications
- Vol. 50 (5) , 445
Open AccessSeroprevalence and risk factors of African horse sickness in equines in central Gondar, Ethiopia
African horse sickness is a severe vector-borne viral disease of equines, associated with high mortality and substantial economic losses. In Ethiopia, where equines are essential for transport and agriculture, the disease remains endemic, yet epidemiological data are limited in many areas. This study aimed to estimate the seroprevalence of African horse sickness virus (AHSV) and describe variation in seropositivity across selected factors in equines in the Central Gondar Zone, Ethiopia. A cross-sectional study was conducted from December 2024 to August 2025, during which 384 serum samples were collected and tested using a blocking enzyme-linked immunosorbent assay (bELISA). Of these, 310 were seropositive, giving an overall seroprevalence of 80.7% (95% CI: 76.4–84.6%). Seroprevalence was slightly higher in East Dembia (81.3%) than in West Dembia (79.9%). Univariable logistic regression showed no statistically significant associations between seropositivity and the evaluated variables ( p > 0.05). Although not statistically significant, higher odds were observed in donkeys and horses compared to mules, in older animals, and under sheltered management conditions. These findings indicate widespread exposure to AHSV in the study area. However, results should be interpreted cautiously due to the descriptive nature of the analysis. Further studies incorporating larger sample sizes, multivariable approaches, and complementary diagnostic methods are recommended to better understand infection dynamics. Strengthened vaccination, improved management practices, and effective vector control remain essential for reducing disease impact.
- Open Access
- 7 May 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (5) , e0334585
Methicillin-resistant Staphylococcus aureus along the beef production line: Phenotypic resistance and mecA phylogeny in two ethiopian municipal abattoirs
Staphylococcus aureus (S. aureus) is a common zoonotic bacteria, responsible for a wide range of infections and is well known for developing resistance to multiple antibiotics. In Ethiopia, information on methicillin-resistant S. aureus (MRSA), particularly from a One-Health perspective, is limited. This study aimed to detect S. aureus , identify MRSA strains, and assess their antibiogram patterns in swab samples collected from two municipal abattoirs in Northwest Ethiopia. A cross-sectional study was conducted between January 2021 and April 2022. A total of 150 swab samples were collected from beef carcasses, abattoir equipment, surfaces, workers’ hands and clothes. Isolation and identification of S. aureus followed ISO 6888−2 standards. Antimicrobial susceptibility was tested against ten commonly used antibiotics using the disk diffusion method. Conventional PCR was used for detection of the mecA gene and Sanger method was used for sequencing. Overall, S. aureus was isolated from 25.3% (38/150) of the samples. The prevalence of S. aureus was 27.1% in beef carcasses, 26.9% in abattoir workers, and 23.1% in the abattoir environment. The prevalence was 22.7% in Bahir Dar and 28.0% in Debre Markos abattoirs. The highest detection rate (35.7%) was from workers’ hands and hooks, while the lowest (11.1%) was from splitting axes. All isolates were susceptible to gentamicin but resistant to penicillin and methicillin. Multidrug resistance was observed in 60.5% of the isolates. Sequencing and phylogenetic analysis of the mecA gene showed that the current isolates were highly similar and clustered closely with mecA from Staphylococcus capitis and Staphylococcus fleurettii , but were distinct from other S. aureus strains. The detection of S. aureus and MRSA in beef carcasses, abattoir environments, and workers highlights potential risks to workers, consumers, and surrounding environments exposed to abattoir waste. Strengthening hygiene and sanitary practices in abattoirs is essential within a One Health framework.
- 7 May 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (5) , e0334585
Open AccessMethicillin-resistant Staphylococcus aureus along the beef production line: Phenotypic resistance and mecA phylogeny in two ethiopian municipal abattoirs
Staphylococcus aureus (S. aureus) is a common zoonotic bacteria, responsible for a wide range of infections and is well known for developing resistance to multiple antibiotics. In Ethiopia, information on methicillin-resistant S. aureus (MRSA), particularly from a One-Health perspective, is limited. This study aimed to detect S. aureus , identify MRSA strains, and assess their antibiogram patterns in swab samples collected from two municipal abattoirs in Northwest Ethiopia. A cross-sectional study was conducted between January 2021 and April 2022. A total of 150 swab samples were collected from beef carcasses, abattoir equipment, surfaces, workers’ hands and clothes. Isolation and identification of S. aureus followed ISO 6888−2 standards. Antimicrobial susceptibility was tested against ten commonly used antibiotics using the disk diffusion method. Conventional PCR was used for detection of the mecA gene and Sanger method was used for sequencing. Overall, S. aureus was isolated from 25.3% (38/150) of the samples. The prevalence of S. aureus was 27.1% in beef carcasses, 26.9% in abattoir workers, and 23.1% in the abattoir environment. The prevalence was 22.7% in Bahir Dar and 28.0% in Debre Markos abattoirs. The highest detection rate (35.7%) was from workers’ hands and hooks, while the lowest (11.1%) was from splitting axes. All isolates were susceptible to gentamicin but resistant to penicillin and methicillin. Multidrug resistance was observed in 60.5% of the isolates. Sequencing and phylogenetic analysis of the mecA gene showed that the current isolates were highly similar and clustered closely with mecA from Staphylococcus capitis and Staphylococcus fleurettii , but were distinct from other S. aureus strains. The detection of S. aureus and MRSA in beef carcasses, abattoir environments, and workers highlights potential risks to workers, consumers, and surrounding environments exposed to abattoir waste. Strengthening hygiene and sanitary practices in abattoirs is essential within a One Health framework.
- Open Access
- 1 January 2026
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 2026 (1) , 3319431
Serosurveillance and Postvaccination Seromonitoring of Peste Des Petits Ruminants in Small Ruminants in Central Gondar Zone, Northwest Ethiopia
Peste des petits ruminants (PPR) is a highly contagious transboundary viral disease of small ruminants caused by the PPR virus (PPRV). Despite Ethiopia’s goal of eradicating PPR by 2027 through a risk‐based vaccination strategy, the disease remains endemic, with 554 outbreaks reported nationwide. This cross‐sectional study was conducted in the North Gondar Zone, Ethiopia, between June 2024 and February 2025 to evaluate antibody responses in vaccinated small ruminants and estimate PPRV seroprevalence in unvaccinated flocks. A multistage cluster sampling design was used to select the study sites, while individual animals were selected using a haphazard sampling approach to approximate random sampling. A total of 600 serum samples were collected, including 300 from vaccinated and 300 from unvaccinated small ruminants; samples from vaccinated animals were obtained ~28 days postvaccination. All samples were tested for anti‐PPRV antibodies using competitive enzyme‐linked immunosorbent assay (c‐ELISA). Overall individual‐level seropositivity in the vaccinated population was 75%, comprising 75.73% in sheep and 72.1% in goats, serving as a proxy measure of flock immunity. In unvaccinated animals, PPRV seroprevalence was 14.33% (95% confidence interval [CI]: 10.6%–18.82%). Multivariable logistic regression identified age and flock size as the main risk factors influencing seropositivity. Adult animals were 2.89 times as likely to be seropositive as young animals (95% CI: 1.17–7.15; p = 0.022), and animals in medium‐sized flocks were more likely to test positive than those in small flocks (AOR = 2.26; 95% CI: 1.11–4.63; p = 0.026). No significant differences were observed across districts, species, sex, production systems, newly introduced animals, or animal movement ( p > 0.05). The observed seropositivity was slightly below the commonly used 80% population immunity target associated with reducing transmission under the PPR eradication framework. The detection of PPRV antibodies in unvaccinated animals indicates previous exposure to PPRV and highlights the need for strengthened surveillance to assess whether active virus circulation persists in the area. To achieve effective control and eventual eradication of PPR, intensified vaccination programs combined with active surveillance are needed. Furthermore, refining vaccination strategies in alignment with global and national eradication plans is essential to establish PPR‐free zones in these districts.
- 1 January 2026
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 2026 (1) , 3319431
Open AccessSerosurveillance and Postvaccination Seromonitoring of Peste Des Petits Ruminants in Small Ruminants in Central Gondar Zone, Northwest Ethiopia
Peste des petits ruminants (PPR) is a highly contagious transboundary viral disease of small ruminants caused by the PPR virus (PPRV). Despite Ethiopia’s goal of eradicating PPR by 2027 through a risk‐based vaccination strategy, the disease remains endemic, with 554 outbreaks reported nationwide. This cross‐sectional study was conducted in the North Gondar Zone, Ethiopia, between June 2024 and February 2025 to evaluate antibody responses in vaccinated small ruminants and estimate PPRV seroprevalence in unvaccinated flocks. A multistage cluster sampling design was used to select the study sites, while individual animals were selected using a haphazard sampling approach to approximate random sampling. A total of 600 serum samples were collected, including 300 from vaccinated and 300 from unvaccinated small ruminants; samples from vaccinated animals were obtained ~28 days postvaccination. All samples were tested for anti‐PPRV antibodies using competitive enzyme‐linked immunosorbent assay (c‐ELISA). Overall individual‐level seropositivity in the vaccinated population was 75%, comprising 75.73% in sheep and 72.1% in goats, serving as a proxy measure of flock immunity. In unvaccinated animals, PPRV seroprevalence was 14.33% (95% confidence interval [CI]: 10.6%–18.82%). Multivariable logistic regression identified age and flock size as the main risk factors influencing seropositivity. Adult animals were 2.89 times as likely to be seropositive as young animals (95% CI: 1.17–7.15; p = 0.022), and animals in medium‐sized flocks were more likely to test positive than those in small flocks (AOR = 2.26; 95% CI: 1.11–4.63; p = 0.026). No significant differences were observed across districts, species, sex, production systems, newly introduced animals, or animal movement ( p > 0.05). The observed seropositivity was slightly below the commonly used 80% population immunity target associated with reducing transmission under the PPR eradication framework. The detection of PPRV antibodies in unvaccinated animals indicates previous exposure to PPRV and highlights the need for strengthened surveillance to assess whether active virus circulation persists in the area. To achieve effective control and eventual eradication of PPR, intensified vaccination programs combined with active surveillance are needed. Furthermore, refining vaccination strategies in alignment with global and national eradication plans is essential to establish PPR‐free zones in these districts.
- Open Access
- 1 January 2026
- Published by Wiley in Veterinary Medicine International
- Vol. 2026 (1) , 3393476
Seroprevalence and Associated Risk Factors of Peste des Petits Ruminants in Small Ruminants in North Shewa, Ethiopia: Implications for Eradication Efforts
Background: Peste des petits ruminants (PPR) are a highly contagious viral disease that causes substantial morbidity, mortality, and economic losses in Ethiopian small ruminants. Despite ongoing efforts to eradicate PPR by 2027, 554 outbreaks were reported nationwide between 2018 and 2022. This cross‐sectional study, conducted from January to May 2024, estimated the seroprevalence of PPR virus (PPRV) and identified associated risk factors among nonvaccinated small ruminants in six districts of North Shewa zone using competitive ELISA (C‐ELISA). Results: Of the 324 serum samples tested, 182 were positive for PPRV antibodies, corresponding to an apparent seroprevalence of 56.17% and a true prevalence of 59.18%. Seroprevalence varied across districts, ranging from 27.78% in Menz‐Mama to 92.59% in Menz‐Gera. In the multivariable mixed‐effects logistic regression model, with peasant association (PA) as a random effect, species and district were significantly associated with seropositivity ( p < 0.05). Goats had approximately four‐fold higher odds of being seropositive than sheep (OR = 4.34; 95% CI: 1.79–12.85; p = 0.002), while animals in Menz‐Gera had markedly higher odds compared to those in Menz‐Mama (OR = 37.77; 95% CI: 8.99–158.63; p < 0.001). No significant associations were observed for age, sex, body condition score, management system/intervention, or agroecology ( p > 0.05). Retrospective analysis indicated that 62 vaccination campaigns were conducted in the zone during the study period, yet 48 PPR outbreaks occurred, resulting in 6415 cases and 951 deaths, corresponding to an overall case fatality rate of 14.82%. Conclusions: PPR appears to remain endemic in North Shewa, with the observed seroprevalence suggesting continued virus circulation, particularly among goats and in high‐risk districts. Despite repeated vaccination campaigns, outbreaks continued to occur during the study period. Therefore, strengthening targeted, risk‐based vaccination, together with improved surveillance and routine seromonitoring, is recommended to support effective PPR control and eradication efforts.
- 1 January 2026
- Published by Wiley in Veterinary Medicine International
- Vol. 2026 (1) , 3393476
Open AccessSeroprevalence and Associated Risk Factors of Peste des Petits Ruminants in Small Ruminants in North Shewa, Ethiopia: Implications for Eradication Efforts
Background: Peste des petits ruminants (PPR) are a highly contagious viral disease that causes substantial morbidity, mortality, and economic losses in Ethiopian small ruminants. Despite ongoing efforts to eradicate PPR by 2027, 554 outbreaks were reported nationwide between 2018 and 2022. This cross‐sectional study, conducted from January to May 2024, estimated the seroprevalence of PPR virus (PPRV) and identified associated risk factors among nonvaccinated small ruminants in six districts of North Shewa zone using competitive ELISA (C‐ELISA). Results: Of the 324 serum samples tested, 182 were positive for PPRV antibodies, corresponding to an apparent seroprevalence of 56.17% and a true prevalence of 59.18%. Seroprevalence varied across districts, ranging from 27.78% in Menz‐Mama to 92.59% in Menz‐Gera. In the multivariable mixed‐effects logistic regression model, with peasant association (PA) as a random effect, species and district were significantly associated with seropositivity ( p < 0.05). Goats had approximately four‐fold higher odds of being seropositive than sheep (OR = 4.34; 95% CI: 1.79–12.85; p = 0.002), while animals in Menz‐Gera had markedly higher odds compared to those in Menz‐Mama (OR = 37.77; 95% CI: 8.99–158.63; p < 0.001). No significant associations were observed for age, sex, body condition score, management system/intervention, or agroecology ( p > 0.05). Retrospective analysis indicated that 62 vaccination campaigns were conducted in the zone during the study period, yet 48 PPR outbreaks occurred, resulting in 6415 cases and 951 deaths, corresponding to an overall case fatality rate of 14.82%. Conclusions: PPR appears to remain endemic in North Shewa, with the observed seroprevalence suggesting continued virus circulation, particularly among goats and in high‐risk districts. Despite repeated vaccination campaigns, outbreaks continued to occur during the study period. Therefore, strengthening targeted, risk‐based vaccination, together with improved surveillance and routine seromonitoring, is recommended to support effective PPR control and eradication efforts.
- Open Access
- 1 January 2025
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 2025 (1)
Spatial and Temporal Dynamics of Peste des Petits Ruminants Outbreaks and Their Clinical Impact in Small Ruminants in North Shewa Zone, Ethiopia: Implications for Eradication
Peste des petits ruminants (PPRs) is an economically significant disease affecting small ruminants. Owing to its impact on livestock and rural livelihoods, Ethiopia joined the global PPR eradication program and implemented risk‐based vaccination strategies in 2018. However, gaps remain in understanding the geographic distribution, seasonal trends, and impact of this disease. To address these gaps, a repeated cross‐sectional study was conducted between September 2018 and August 2024 in the North Shewa Zone to confirm PPR outbreaks via rapid antigen detection methods, specifically the pen‐side test and dipstick technique. In addition, a retrospective analysis was performed to assess the spatial and temporal distributions of outbreaks, along with associated morbidity, mortality, and case fatality rates. The results revealed 48 confirmed PPR outbreaks over 6 years, occurring in 15 out of 24 districts, with an average of 8 outbreaks annually and a 0.33 proportion of affected districts, indicating low and localized spread. A total of 192 clinical samples were collected from symptomatic sheep and goats, all of which tested positive for PPRV. In total, 6415 PPR cases were documented, with a morbidity rate of 0.72%, a mortality rate of 0.11% (951 deaths), and a case fatality rate of 14.82%. Kewet had the highest number of outbreaks (7), whereas Mojana‐Wedera recorded the highest number of cases (2718). Seasonally, 60% of the outbreaks occurred during the long rainy season, leading to 4472 cases and a fatality rate of 16.79%. Yearly trends showed consistent patterns, with 2023 having the highest number of outbreaks (15) and 2021 having the fewest (5). The year 2024 had the highest number of cases (2706). Despite continued viral circulation, the low morbidity and mortality rates, relative to the high transmissibility and fatality rates of the PPR in naïve populations (infection rates of up to 100% and mortality rates of 10%–90%), reflect significant control progress. While PPR remains endemic in the North Shewa Zone, the reduced incidence and clinical impact indicate measurable advancements toward eradication. Nonetheless, recurrent outbreaks across seasons and districts necessitate sustained, adaptive interventions. The study recommends strengthening surveillance, enhancing postvaccination sero‐monitoring, and optimizing vaccine allocation to accelerate eradication.
- 1 January 2025
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 2025 (1)
Open AccessSpatial and Temporal Dynamics of Peste des Petits Ruminants Outbreaks and Their Clinical Impact in Small Ruminants in North Shewa Zone, Ethiopia: Implications for Eradication
Peste des petits ruminants (PPRs) is an economically significant disease affecting small ruminants. Owing to its impact on livestock and rural livelihoods, Ethiopia joined the global PPR eradication program and implemented risk‐based vaccination strategies in 2018. However, gaps remain in understanding the geographic distribution, seasonal trends, and impact of this disease. To address these gaps, a repeated cross‐sectional study was conducted between September 2018 and August 2024 in the North Shewa Zone to confirm PPR outbreaks via rapid antigen detection methods, specifically the pen‐side test and dipstick technique. In addition, a retrospective analysis was performed to assess the spatial and temporal distributions of outbreaks, along with associated morbidity, mortality, and case fatality rates. The results revealed 48 confirmed PPR outbreaks over 6 years, occurring in 15 out of 24 districts, with an average of 8 outbreaks annually and a 0.33 proportion of affected districts, indicating low and localized spread. A total of 192 clinical samples were collected from symptomatic sheep and goats, all of which tested positive for PPRV. In total, 6415 PPR cases were documented, with a morbidity rate of 0.72%, a mortality rate of 0.11% (951 deaths), and a case fatality rate of 14.82%. Kewet had the highest number of outbreaks (7), whereas Mojana‐Wedera recorded the highest number of cases (2718). Seasonally, 60% of the outbreaks occurred during the long rainy season, leading to 4472 cases and a fatality rate of 16.79%. Yearly trends showed consistent patterns, with 2023 having the highest number of outbreaks (15) and 2021 having the fewest (5). The year 2024 had the highest number of cases (2706). Despite continued viral circulation, the low morbidity and mortality rates, relative to the high transmissibility and fatality rates of the PPR in naïve populations (infection rates of up to 100% and mortality rates of 10%–90%), reflect significant control progress. While PPR remains endemic in the North Shewa Zone, the reduced incidence and clinical impact indicate measurable advancements toward eradication. Nonetheless, recurrent outbreaks across seasons and districts necessitate sustained, adaptive interventions. The study recommends strengthening surveillance, enhancing postvaccination sero‐monitoring, and optimizing vaccine allocation to accelerate eradication.
- 2 September 2024
- Published by Taylor & Francis in Avian Pathology
- Vol. 54 (1) , 108-119
Seroprevalence of infectious bursal disease and its associated risk factors in Ethiopia: a systematic review and meta-analysis
Although the poultry population is an integral part of Ethiopia's Gross Domestic Product (GDP) due to various infectious diseases such as infectious bursal disease (IBD), the expected economic impact in the country remains limited. The status of the diseases in Ethiopia is obscured, and thus, a systematic review and meta-analysis were employed to estimate the overall pooled prevalence of IBD in Ethiopia. Meta-analysis was conducted to determine the effects of each identified risk factor, while meta-regression and sub-group analysis were employed to assess the relationship between study-level covariates and effect size. The pooled prevalence of IBD in Ethiopia was 69.4% (95%CI 30.7 -96.2), while the pooled logit prevalence was 0.94 (95% CI: 0.68 - 1.20) with significant inter-study variance (Q test = 948.28, df = 43, p < 0.001; τ2 = 0.71, I2 = 95.47%). A small study effect was detected in the regression-based Egger test (Prob > |z| < 0.0001). Significant variation was observed among different groups such as sex, age, breed, and type of farm of the chickens. The effect size for the study period from 2018 to 2021 was significantly lower by -0.204 compared to the study period from 2009 to 2015 (p < 0.0001. In conclusion, the IBD pooled prevalence estimate is high, even though the number of studies in the country is insufficient. The high prevalence of the disease requires prompt attention from all stakeholders in the sector to bring it under control through comprehensive disease prevention and control intervention strategies.
- 2 September 2024
- Published by Taylor & Francis in Avian Pathology
- Vol. 54 (1) , 108-119
Seroprevalence of infectious bursal disease and its associated risk factors in Ethiopia: a systematic review and meta-analysis
Although the poultry population is an integral part of Ethiopia's Gross Domestic Product (GDP) due to various infectious diseases such as infectious bursal disease (IBD), the expected economic impact in the country remains limited. The status of the diseases in Ethiopia is obscured, and thus, a systematic review and meta-analysis were employed to estimate the overall pooled prevalence of IBD in Ethiopia. Meta-analysis was conducted to determine the effects of each identified risk factor, while meta-regression and sub-group analysis were employed to assess the relationship between study-level covariates and effect size. The pooled prevalence of IBD in Ethiopia was 69.4% (95%CI 30.7 -96.2), while the pooled logit prevalence was 0.94 (95% CI: 0.68 - 1.20) with significant inter-study variance (Q test = 948.28, df = 43, p < 0.001; τ2 = 0.71, I2 = 95.47%). A small study effect was detected in the regression-based Egger test (Prob > |z| < 0.0001). Significant variation was observed among different groups such as sex, age, breed, and type of farm of the chickens. The effect size for the study period from 2018 to 2021 was significantly lower by -0.204 compared to the study period from 2009 to 2015 (p < 0.0001. In conclusion, the IBD pooled prevalence estimate is high, even though the number of studies in the country is insufficient. The high prevalence of the disease requires prompt attention from all stakeholders in the sector to bring it under control through comprehensive disease prevention and control intervention strategies.
- Open Access
- 1 June 2022
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 15, 2937-2948
A Preliminary Investigation on a Commercial Ovine Pasteurellosis Vaccine Using Clinical and Pathological Endpoints
Introduction: In this study we aimed to provide preliminary evidence on the safety and efficacy of the currently used ovine pasteurellosis vaccine in Ethiopia using clinical and pathological endpoints. Methods: Twenty, conventionally reared, apparently healthy, seronegative male lambs, were randomly classified into two groups of 10 animals as “vaccinated-challenged” and ”unvaccinated-challenged controls”. The first group received 1 mL of the licensed Pasteurella multocida biotype A based vaccine subcutaneously while the second group received phosphate-buffered saline as a placebo. Following vaccination, lambs were monitored for one month for potential vaccine adverse reactions. Five weeks postvaccination, all lambs were immunosuppressed using dexamethasone, and intratracheally challenged with 5.2× 109 CFU/mL live Mannheimia haemolytica A1 (clinical isolates). Then, all lambs were followed up for eight days for clinical examination and necropsied on the ninth day postchallenge for pathological investigation. Results: There were no safety issues recorded during the study. In terms of clinical signs, lambs developed fever, depression, mucoid bilateral oculonasal discharge, coughing and sneezing regardless of their vaccination status. Fisher’s exact test between vaccination status and each clinical sign showed a statistically insignificant association (p> 0.05). The main pathological findings in both groups were pulmonary congestion, atelectasis, emphysema, and suppurative bronchopneumonia. Consolidation lung lesion score of +1 (5/10 of vaccinated, 6/10 of unvaccinated) and +2 (3/10 of vaccinated, 4/10 of unvaccinated) were recorded in a statistically indifferent manner among both vaccinated and nonvaccinated groups (p> 0.05). Discussion and Conclusion: Collectively, the results suggested that the vaccine posed no safety concern and presumably lacks protective efficacy against local isolates. However, the study did not analyze antibody titer and their functionality using serum bactericidal assays. Further confirmatory studies could provide more evidence on the vaccine efficacy. Safety should further be assessed in a field setting involving a large number of animals to enable detection of rare vaccine adverse events.
- 1 June 2022
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 15, 2937-2948
Open AccessA Preliminary Investigation on a Commercial Ovine Pasteurellosis Vaccine Using Clinical and Pathological Endpoints
Introduction: In this study we aimed to provide preliminary evidence on the safety and efficacy of the currently used ovine pasteurellosis vaccine in Ethiopia using clinical and pathological endpoints. Methods: Twenty, conventionally reared, apparently healthy, seronegative male lambs, were randomly classified into two groups of 10 animals as “vaccinated-challenged” and ”unvaccinated-challenged controls”. The first group received 1 mL of the licensed Pasteurella multocida biotype A based vaccine subcutaneously while the second group received phosphate-buffered saline as a placebo. Following vaccination, lambs were monitored for one month for potential vaccine adverse reactions. Five weeks postvaccination, all lambs were immunosuppressed using dexamethasone, and intratracheally challenged with 5.2× 109 CFU/mL live Mannheimia haemolytica A1 (clinical isolates). Then, all lambs were followed up for eight days for clinical examination and necropsied on the ninth day postchallenge for pathological investigation. Results: There were no safety issues recorded during the study. In terms of clinical signs, lambs developed fever, depression, mucoid bilateral oculonasal discharge, coughing and sneezing regardless of their vaccination status. Fisher’s exact test between vaccination status and each clinical sign showed a statistically insignificant association (p> 0.05). The main pathological findings in both groups were pulmonary congestion, atelectasis, emphysema, and suppurative bronchopneumonia. Consolidation lung lesion score of +1 (5/10 of vaccinated, 6/10 of unvaccinated) and +2 (3/10 of vaccinated, 4/10 of unvaccinated) were recorded in a statistically indifferent manner among both vaccinated and nonvaccinated groups (p> 0.05). Discussion and Conclusion: Collectively, the results suggested that the vaccine posed no safety concern and presumably lacks protective efficacy against local isolates. However, the study did not analyze antibody titer and their functionality using serum bactericidal assays. Further confirmatory studies could provide more evidence on the vaccine efficacy. Safety should further be assessed in a field setting involving a large number of animals to enable detection of rare vaccine adverse events.
- Open Access
- 1 April 2022
- Published by Taylor & Francis in Veterinary Medicine: Research and Reports
- Vol. ume 13, 75-83
Isolation and Molecular Detection of Pasteurellosis from Pneumonic Sheep in Selected Areas of Amhara Region, Ethiopia: An Implication for Designing Effective Ovine Pasteurellosis Vaccine
Introduction: Pneumonic pasteurellosis mainly caused by bacterial species of Mannheimia, Pasteurella, and Bibersteinia causes a significant financial loss to the sheep production sector through reduced productivity and high mortality. There is a dearth of information on the major agents involved in the disease in the Amhara region, Ethiopia. Therefore, the aim of this study was to isolate and molecularly confirm Mannheimia, Pasteurella, and Bibersteinia from nasal swabs of sheep suspected of pneumonic pasteurellosis in selected areas of the Amhara region. Methods: Isolation and phenotypic characterization were performed using microbiological and biochemical testing according to standard methods. Molecular confirmation of isolates was done through amplification of virulence associated genes, PHSAA and Rpt2, of Mannheimia hemolyticausing multiplex PCR. Results: Accordingly, 46 out of 141 (32.62%) samples were presumably identified as M. hemolytica with no Pasteurella multocida and Bibersteinia trehalosi. Seven (n=7) out of the 46 isolates tested positive for either of the two virulence genes. Discussion and conclusion: The finding of this study is indicative that M. hemolytica is the main bacteria linked with pneumonic pasteurellosis in the study area which suggests the need to develop a polyvalent vaccine including strains of M. hemolytica or its antigenic determinants. However, the role of other bacterial, viral, and parasitic agents in the cases investigated should also be considered.
- 1 April 2022
- Published by Taylor & Francis in Veterinary Medicine: Research and Reports
- Vol. ume 13, 75-83
Open AccessIsolation and Molecular Detection of Pasteurellosis from Pneumonic Sheep in Selected Areas of Amhara Region, Ethiopia: An Implication for Designing Effective Ovine Pasteurellosis Vaccine
Introduction: Pneumonic pasteurellosis mainly caused by bacterial species of Mannheimia, Pasteurella, and Bibersteinia causes a significant financial loss to the sheep production sector through reduced productivity and high mortality. There is a dearth of information on the major agents involved in the disease in the Amhara region, Ethiopia. Therefore, the aim of this study was to isolate and molecularly confirm Mannheimia, Pasteurella, and Bibersteinia from nasal swabs of sheep suspected of pneumonic pasteurellosis in selected areas of the Amhara region. Methods: Isolation and phenotypic characterization were performed using microbiological and biochemical testing according to standard methods. Molecular confirmation of isolates was done through amplification of virulence associated genes, PHSAA and Rpt2, of Mannheimia hemolyticausing multiplex PCR. Results: Accordingly, 46 out of 141 (32.62%) samples were presumably identified as M. hemolytica with no Pasteurella multocida and Bibersteinia trehalosi. Seven (n=7) out of the 46 isolates tested positive for either of the two virulence genes. Discussion and conclusion: The finding of this study is indicative that M. hemolytica is the main bacteria linked with pneumonic pasteurellosis in the study area which suggests the need to develop a polyvalent vaccine including strains of M. hemolytica or its antigenic determinants. However, the role of other bacterial, viral, and parasitic agents in the cases investigated should also be considered.
- Open Access
- 13 November 2021
- Published by Wiley in The Scientific World Journal
- Vol. 2021, 1-10
Seroprevalence and Associated Risk Factors of Infectious Bronchitis Virus in Chicken in Northwest Ethiopia
Avian infectious bronchitis virus is a highly contagious disease occurring in respiratory, urogenital, and reproductive tissues of chicken causing considerable losses due to death, egg drop, and reduced production. This preliminary study was conducted to investigate the prevalence of antibodies against infectious bronchitis virus (IBV) and to assess the potential risk factors in chickens of northwest Ethiopia. A cross-sectional study was conducted from November 2020 to June 2021. A total of 768 serum samples from three zones were collected. To investigate the presence of antibodies against IBV, the indirect ELISA serological test was applied. Positivity for anti-IBV antibodies was observed in 23.96% (95% CI: 20.98–27.14) of the samples. The mixed-effect logistic regression analysis of potential risk factors showed that IBV prevalence was significantly higher in young chickens than adults ( ) and higher in intensive farm type than in extensive type ( ). Based on the production purposes of the chickens, the odds of seropositivity for IB was significantly higher in layers than in broilers ( ) and dual purposes ( ). This study revealed higher seroprevalence in farms which had the “all-in-all-out” rearing method than in farms with different batches in one house with a significant difference ( ), higher seroprevalence in the poor ventilated type than in good ones ( ), and higher seroprevalence in the houses that did not remove used litter at all than houses of completely disposed and partially disposed litter ( ). Moreover, disinfection of houses had significant effect on the occurrence of IB. Having personal protective equipment was significantly affecting the occurrence of IB, being higher in the farms that have no wearing clothes and shoe than in those having wearing clothes and shoe ( ). In conclusion, the seroprevalence finding in the present study indicated that the organism is circulating among the population of chickens and high enough to cause significant economic losses Therefore, poultry houses should be cleaned, disinfected, and well ventilated and farm attendants should have separate farm shoe and clothes. Further studies on the virus isolation and molecular characterization of the target gene are needed in the study area.
- 13 November 2021
- Published by Wiley in The Scientific World Journal
- Vol. 2021, 1-10
Open AccessSeroprevalence and Associated Risk Factors of Infectious Bronchitis Virus in Chicken in Northwest Ethiopia
Avian infectious bronchitis virus is a highly contagious disease occurring in respiratory, urogenital, and reproductive tissues of chicken causing considerable losses due to death, egg drop, and reduced production. This preliminary study was conducted to investigate the prevalence of antibodies against infectious bronchitis virus (IBV) and to assess the potential risk factors in chickens of northwest Ethiopia. A cross-sectional study was conducted from November 2020 to June 2021. A total of 768 serum samples from three zones were collected. To investigate the presence of antibodies against IBV, the indirect ELISA serological test was applied. Positivity for anti-IBV antibodies was observed in 23.96% (95% CI: 20.98–27.14) of the samples. The mixed-effect logistic regression analysis of potential risk factors showed that IBV prevalence was significantly higher in young chickens than adults ( ) and higher in intensive farm type than in extensive type ( ). Based on the production purposes of the chickens, the odds of seropositivity for IB was significantly higher in layers than in broilers ( ) and dual purposes ( ). This study revealed higher seroprevalence in farms which had the “all-in-all-out” rearing method than in farms with different batches in one house with a significant difference ( ), higher seroprevalence in the poor ventilated type than in good ones ( ), and higher seroprevalence in the houses that did not remove used litter at all than houses of completely disposed and partially disposed litter ( ). Moreover, disinfection of houses had significant effect on the occurrence of IB. Having personal protective equipment was significantly affecting the occurrence of IB, being higher in the farms that have no wearing clothes and shoe than in those having wearing clothes and shoe ( ). In conclusion, the seroprevalence finding in the present study indicated that the organism is circulating among the population of chickens and high enough to cause significant economic losses Therefore, poultry houses should be cleaned, disinfected, and well ventilated and farm attendants should have separate farm shoe and clothes. Further studies on the virus isolation and molecular characterization of the target gene are needed in the study area.